Style | Citing Format |
---|---|
MLA | Mousavinejad S, et al.. "Ethical Considerations in Conducting Clinical Trials." International Journal of Medical Toxicology and Forensic Medicine, vol. 11, no. 4, 2021, pp. 34863-. |
APA | Mousavinejad S, Bazmi S, Rezaeitavirani M, Shamsigooshki E, Enjoo SA, Kiani M (2021). Ethical Considerations in Conducting Clinical Trials. International Journal of Medical Toxicology and Forensic Medicine, 11(4), 34863-. |
Chicago | Mousavinejad S, Bazmi S, Rezaeitavirani M, Shamsigooshki E, Enjoo SA, Kiani M. "Ethical Considerations in Conducting Clinical Trials." International Journal of Medical Toxicology and Forensic Medicine 11, no. 4 (2021): 34863-. |
Harvard | Mousavinejad S et al. (2021) 'Ethical Considerations in Conducting Clinical Trials', International Journal of Medical Toxicology and Forensic Medicine, 11(4), pp. 34863-. |
Vancouver | Mousavinejad S, Bazmi S, Rezaeitavirani M, Shamsigooshki E, Enjoo SA, Kiani M. Ethical Considerations in Conducting Clinical Trials. International Journal of Medical Toxicology and Forensic Medicine. 2021;11(4):34863-. |
BibTex | @article{ author = {Mousavinejad S and Bazmi S and Rezaeitavirani M and Shamsigooshki E and Enjoo SA and Kiani M}, title = {Ethical Considerations in Conducting Clinical Trials}, journal = {International Journal of Medical Toxicology and Forensic Medicine}, volume = {11}, number = {4}, pages = {34863-}, year = {2021} } |
RIS | TY - JOUR AU - Mousavinejad S AU - Bazmi S AU - Rezaeitavirani M AU - Shamsigooshki E AU - Enjoo SA AU - Kiani M TI - Ethical Considerations in Conducting Clinical Trials JO - International Journal of Medical Toxicology and Forensic Medicine VL - 11 IS - 4 SP - 34863 EP - PY - 2021 ER - |